HSAQ
Health Sciences Acquisitions Corporation 2 [HSAQ] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
HSAQ Stock Summary
In the News
HSAQ Financial details
Company Rating
-
Market Cap
149.23M
Income
-36.18M
Revenue
2.5M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
25 Jan 2023
P/E
-31244.63
Forward P/E
-
PEG
-846.11
P/S
128.21
P/B
3688.47
P/C
-
P/FCF
-9.53
Quick Ratio
10.55
Current Ratio
10.77
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.08
EPS next Y
-
EPS next Q
-
EPS this Y
737.99%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-54.21%
EPS Q/Q
33.33%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-9%
ROE
-32%
ROC
-0.1%
Gross Margin
96%
Oper. Margin
-1048%
Profit Margin
-1012%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.41-13.8
52W High
+2.38%
52W Low
+47.89%
RSI
-
Rel Volume
1.68
Avg Volume
71.38K
Volume
119.61K
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
25.21%
-
-
-
-
Beta
-
-
-
Volatility
1.16%, 1.16%
Prev Close
0%
Price
13.31
Change
23.24%
Company Profile
- Volume Average 71.38K
- Market Capitalization 149.23M
- CEO Dr. Roderick Tze Ian Wong M.D.
- Headquarters New York,NY,US
- IPO Date 2020-08-04
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
